| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.00056 | 1 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.00045 | 1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00034 | 1 |